Waters Corporation (WAT) Earnings

Waters Corporation

WAT · NYSE

Sep 2026upcoming

Next quarter

Consensus is $3.97 EPS for Sep 2026 across 3 estimates, ranging $3.95 to $4.00.

WAT Jun 2026

Reported Aug 4, 2026

Beat 1.33%

EPS estimate: $3.01
EPS actual: $3.05
Revenue estimate: —
Revenue actual: —
1-day move: —

Call highlights have not been generated for this quarter.

Symbol: WAT
Type: Stock
Sector: Industrials
Industry: Biotechnology: Laboratory Analytical Instruments
Country: North America
Exchange: NYSE

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide.

Key Issues

Bullish view

Waters raised 2026 guidance, while second-quarter earnings and revenue exceeded estimates by 1.33% and 1.25%, suggesting the forward outlook remains stronger than the reported quarter.

Bearish view

The quarter included a $136 million net loss and a $1.39 GAAP loss per share, versus $147 million of net income and $2.47 EPS a year earlier, raising questions about earnings quality and near-term profitability.

Analyst Consensus

See all

Buy

17 analysts

$401

Current

—

Low

$420

Average

—

High

Average target implies +4.74% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Agilent Technologies, Inc.A · NYSE$141.16